c-MYC Triggers Lipid Remodelling During Early Somatic Cell Reprogramming to Pluripotency.


Journal

Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767

Informations de publication

Date de publication:
12 2021
Historique:
accepted: 06 08 2021
pubmed: 4 9 2021
medline: 7 4 2022
entrez: 3 9 2021
Statut: ppublish

Résumé

Metabolic rewiring and mitochondrial dynamics remodelling are hallmarks of cell reprogramming, but the roles of the reprogramming factors in these changes are not fully understood. Here we show that c-MYC induces biosynthesis of fatty acids and increases the rate of pentose phosphate pathway. Time-course profiling of fatty acids and complex lipids during cell reprogramming using lipidomics revealed a profound remodelling of the lipid content, as well as the saturation and length of their acyl chains, in a c-MYC-dependent manner. Pluripotent cells displayed abundant cardiolipins and scarce phosphatidylcholines, with a prevalence of monounsaturated acyl chains. Cells undergoing cell reprogramming showed an increase in mitochondrial membrane potential that paralleled that of mitochondrial-specific cardiolipins. We conclude that c-MYC controls the rewiring of somatic cell metabolism early in cell reprogramming by orchestrating cell proliferation, synthesis of macromolecular components and lipid remodelling, all necessary processes for a successful phenotypic transition to pluripotency. c-MYC promotes anabolic metabolism, mitochondrial fitness and lipid remodelling early in cell reprogramming. A high rate of aerobic glycolysis is crucial to provide intermediaries for biosynthetic pathways. To ensure the availability of nucleotides, amino acids and lipids for cell proliferation, cells must provide with a constant flux of the elemental building blocks for macromolecule assembly and fulfil the anabolic demands to reach the critical cellular mass levels to satisfactorily undergo cell division. A high rate of aerobic glycolysis is induced by c-MYC, increasing the amounts of intracellular Glucose-6-phosphate (G6P), fructose-6-phosphate (F6P), and glyceraldehyde-3-phosphate (GA3P), which can all enter pentose phosphate pathway (PPP) to produce Ribose-5-Phosphate (R5P) and NADPH, which are necessary for the biosynthesis of biomolecules such as proteins, nucleic acids, or lipids. C-MYC-dependent activation of glucose-6-phosphate dehydrogenase (G6PD) may play a critical role in the shunting of G6P to PPP and generation of NADPH. High glycolytic flux increases the amounts of dihydroxyacetone phosphate (DHAP), which is crucial for biosynthesis of phospholipids and triacylglycerols, and pyruvate (Pyr), which can be converted to citrate (Cit) in the mitochondria and enter the biosynthesis of fatty acids (FA). During cell reprogramming, c-MYC-dependent lipid remodelling leads to Polyunsaturated Fatty Acid (PUFA) downregulation and Monounsaturated Fatty Acid (MUFA) upregulation, which may play critical roles in cytoarchitectural remodelling of cell membrane or non-canonical autophagy, respectively. Cardiolipin (pink dots) rise early in cell reprogramming correlates with an increase in mitochondrial fitness, suggesting that c-MYC may restore proper levels of cardiolipins and antioxidant proteins, such as UCP2, to guarantee an optimal mitochondrial function while upholding ROS levels, reinforcing the idea of cell rejuvenation early in cell reprogramming.

Identifiants

pubmed: 34476741
doi: 10.1007/s12015-021-10239-2
pii: 10.1007/s12015-021-10239-2
pmc: PMC8599373
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2245-2261

Subventions

Organisme : NCI NIH HHS
ID : P30 CA014195
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Cell Stem Cell. 2010 Jul 2;7(1):51-63
pubmed: 20621050
Nature. 2013 Jan 10;493(7431):226-30
pubmed: 23201681
J Cell Sci. 1969 May;4(3):645-54
pubmed: 5817088
Prog Lipid Res. 2016 Jul;63:120-31
pubmed: 27233110
Cell Stem Cell. 2017 Mar 2;20(3):291-292
pubmed: 28257705
Cell Rep. 2016 May 3;15(5):919-925
pubmed: 27117405
Int J Cancer. 2005 May 20;115(1):19-35
pubmed: 15657900
Cancer Res. 2003 Jul 1;63(13):3799-804
pubmed: 12839976
Oncogene. 2005 Sep 15;24(41):6314-22
pubmed: 16007201
Nat Rev Mol Cell Biol. 2017 Jun;18(6):361-374
pubmed: 28356571
Free Radic Biol Med. 2010 May 15;48(10):1286-95
pubmed: 20176101
Nat Commun. 2020 Mar 24;11(1):1545
pubmed: 32210226
Trends Biochem Sci. 2014 Aug;39(8):347-54
pubmed: 25037503
Cell Metab. 2011 Aug 3;14(2):264-71
pubmed: 21803296
Cancer Cell. 2005 Oct;8(4):311-21
pubmed: 16226706
Chem Phys Lipids. 2014 Apr;179:42-8
pubmed: 24220496
Nat Rev Mol Cell Biol. 2008 Feb;9(2):99-111
pubmed: 18216767
FEBS J. 2020 Jan;287(1):108-121
pubmed: 31361392
Curr Opin Cell Biol. 2016 Aug;41:25-32
pubmed: 27062546
Biochem Biophys Res Commun. 2019 Oct 29;519(1):100-105
pubmed: 31481234
Nat Cell Biol. 2015 Nov;17(11):1379-87
pubmed: 26502054
Science. 2014 Aug 8;345(6197):693-7
pubmed: 25104391
Cancer Res. 2006 May 15;66(10):5287-94
pubmed: 16707454
Cancer Res. 2010 May 1;70(9):3780-90
pubmed: 20388789
Biochemistry. 2012 May 15;51(19):4004-14
pubmed: 22524567
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Cell Stem Cell. 2010 Jul 2;7(1):64-77
pubmed: 20621051
Annu Rev Cell Dev Biol. 2011;27:441-64
pubmed: 21985671
Cell Metab. 2015 Mar 3;21(3):392-402
pubmed: 25738455
Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24
pubmed: 18216768
Nature. 2013 Oct 24;502(7472):462-71
pubmed: 24153299
BMC Genomics. 2006 Jun 08;7:142
pubmed: 16762068
Cell Metab. 2008 Jan;7(1):11-20
pubmed: 18177721
EMBO J. 2011 Nov 15;30(24):4860-73
pubmed: 22085932
Biochim Biophys Acta. 2015 May;1849(5):506-16
pubmed: 24704206
Cells. 2019 Jul 16;8(7):
pubmed: 31315173
Nat Rev Mol Cell Biol. 2018 May;19(5):281-296
pubmed: 29410529
Biochim Biophys Acta. 2009 Oct;1788(10):2059-68
pubmed: 19422785
EMBO J. 2017 May 15;36(10):1330-1347
pubmed: 28377463
Anal Chem. 2019 Jan 2;91(1):836-845
pubmed: 30500173
Cell Metab. 2017 May 2;25(5):1103-1117.e6
pubmed: 28467928
Stem Cells Int. 2017;2017:8073721
pubmed: 28484497
Cell Stem Cell. 2015 May 7;16(5):547-55
pubmed: 25865501
Nature. 2013 Jan 17;493(7432):310-1
pubmed: 23325209
Dev Cell. 2010 Apr 20;18(4):675-85
pubmed: 20412781
Biophys J. 2011 May 4;100(9):2184-92
pubmed: 21539786
Nat Commun. 2016 Jul 12;7:12148
pubmed: 27401954
Nat Cell Biol. 2008 Feb;10(2):194-201
pubmed: 18223644
Cell Cycle. 2016 Dec;15(23):3240-3250
pubmed: 27753531
Annu Rev Pharmacol Toxicol. 2009;49:123-50
pubmed: 18834304
Cell. 2016 Dec 15;167(7):1719-1733.e12
pubmed: 27984723
Biochimie. 2017 Nov;142:102-111
pubmed: 28842204
Elife. 2016 Jul 26;5:
pubmed: 27458799
FEBS Lett. 2002 Sep 25;528(1-3):35-9
pubmed: 12297275
Nat Commun. 2016 Mar 31;7:11124
pubmed: 27030341
EMBO J. 2015 Mar 4;34(5):609-23
pubmed: 25603933
EMBO J. 2015 Apr 15;34(8):1025-41
pubmed: 25586377
Exp Gerontol. 2020 May;133:110870
pubmed: 32045634
Am J Physiol Heart Circ Physiol. 2015 Jul 1;309(1):H147-56
pubmed: 25910810
Science. 2009 Nov 27;326(5957):1208-12
pubmed: 19965462
Biochim Biophys Acta Biomembr. 2017 Jun;1859(6):1156-1163
pubmed: 28336315
Hum Mol Genet. 2015 Aug 15;24(16):4698-709
pubmed: 26025377
Biosci Rep. 1985 May;5(5):393-400
pubmed: 3896338
Biochem Biophys Res Commun. 2006 Oct 6;348(4):1472-8
pubmed: 16920071
Stem Cells Int. 2016;2016:1816525
pubmed: 26839556
Nat Chem Biol. 2010 Mar;6(3):202-204
pubmed: 20081855
Elife. 2014 Jan 01;3:e01879
pubmed: 24596153
Cell Stem Cell. 2017 Mar 2;20(3):303-314.e5
pubmed: 28041894
Prog Lipid Res. 2014 Jan;53:124-44
pubmed: 24362249
Cell Cycle. 2013 Jan 15;12(2):207-18
pubmed: 23287468
Nature. 2008 Jul 3;454(7200):49-55
pubmed: 18509334
Stem Cell Reports. 2018 Dec 11;11(6):1479-1492
pubmed: 30472011
Annu Rev Physiol. 2016;78:533-61
pubmed: 26734886
Stem Cells. 2011 Sep;29(9):1338-48
pubmed: 21732474
Stem Cells. 2010 Apr;28(4):721-33
pubmed: 20201066
Cancer Res. 2005 Aug 1;65(15):6719-25
pubmed: 16061653

Auteurs

Javier Prieto (J)

Departamento Biología Celular, Biología Funcional y Antropología Física, Universitat de València, 46100, Burjassot, Valencia, Spain.
Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, 92037, USA.

Juan Carlos García-Cañaveras (JC)

Biomarkers and Precision Medicine Unit, Instituto de Investigación Sanitaria La Fe, 46026, Valencia, Spain.

Marian León (M)

Departamento Biología Celular, Biología Funcional y Antropología Física, Universitat de València, 46100, Burjassot, Valencia, Spain.

Ramón Sendra (R)

Departamento de Bioquímica y Biología Molecular, Universitat de València, 46100, Burjassot, Valencia, Spain.

Xavier Ponsoda (X)

Departamento Biología Celular, Biología Funcional y Antropología Física, Universitat de València, 46100, Burjassot, Valencia, Spain.

Juan Carlos Izpisúa Belmonte (JC)

Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, 92037, USA.

Agustín Lahoz (A)

Biomarkers and Precision Medicine Unit, Instituto de Investigación Sanitaria La Fe, 46026, Valencia, Spain. agustin.lahoz@uv.es.

Josema Torres (J)

Departamento Biología Celular, Biología Funcional y Antropología Física, Universitat de València, 46100, Burjassot, Valencia, Spain. josema.torres@uv.es.
Instituto de Investigación Sanitaria (INCLIVA), 46010, Valencia, Spain. josema.torres@uv.es.

Articles similaires

Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals

Glucose and glutamine drive hepatitis E virus replication.

Shaheen Khan, Suruchi Aggarwal, Pooja Bhatia et al.
1.00
Glutamine Virus Replication Hepatitis E virus Glucose Glycolysis
Animals Podocytes Fasting Humans Male
Humans Insulin Resistance Muscle, Skeletal Oxidative Stress Oxidation-Reduction

Classifications MeSH